These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35976559)

  • 41. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
    Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
    PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
    Howes RE; Piel FB; Patil AP; Nyangiri OA; Gething PW; Dewi M; Hogg MM; Battle KE; Padilla CD; Baird JK; Hay SI
    PLoS Med; 2012; 9(11):e1001339. PubMed ID: 23152723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study.
    Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
    Malar J; 2015 Mar; 14():126. PubMed ID: 25889063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
    Pukrittayakamee S; Jittamala P; Watson JA; Hanboonkunupakarn B; Leungsinsiri P; Poovorawan K; Chotivanich K; Bancone G; Chu CS; Imwong M; Day NPJ; Taylor WRJ; White NJ
    Elife; 2024 Feb; 12():. PubMed ID: 38319064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The reality of using primaquine.
    Burgoine KL; Bancone G; Nosten F
    Malar J; 2010 Dec; 9():376. PubMed ID: 21184691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
    Satyagraha AW; Sadhewa A; Panggalo LV; Subekti D; Elyazar I; Soebianto S; Mahpud N; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009610. PubMed ID: 34270547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
    Chamchoy K; Sudsumrit S; Thita T; Krudsood S; Patrapuvich R; Boonyuen U
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010986. PubMed ID: 36508454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
    Vizzi E; Bastidas G; Hidalgo M; Colman L; Pérez HA
    Malar J; 2016 Jan; 15():19. PubMed ID: 26753754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Spectrum of Primaquine-induced Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year Hospitalization-based Study From the Brazilian Amazon.
    Brito-Sousa JD; Santos TC; Avalos S; Fontecha G; Melo GC; Val F; Siqueira AM; Alecrim GC; Bassat Q; Lacerda MVG; Monteiro WM
    Clin Infect Dis; 2019 Sep; 69(8):1440-1442. PubMed ID: 30753364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
    Satyagraha AW; Sadhewa A; Baramuli V; Elvira R; Ridenour C; Elyazar I; Noviyanti R; Coutrier FN; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003602. PubMed ID: 25746733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
    Sulistyaningrum N; Arlinda D; Hutagalung J; Sunarno S; Oktoberia IS; Handayani S; Ekowatiningsih R; Yusnita EA; Prasetyorini B; Rizki A; Tjitra E; Na-Bangchang K; Chaijaroenkul W
    Am J Trop Med Hyg; 2020 Aug; 103(2):760-766. PubMed ID: 32602432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
    Taylor WRJ; Meagher N; Ley B; Thriemer K; Bancone G; Satyagraha A; Assefa A; Chand K; Chau NH; Dhorda M; Degaga TS; Ekawati LL; Hailu A; Hasanzai MA; Naddim MN; Pasaribu AP; Rahim AG; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Dondorp A; von Seidlein L; Simpson JA; White NJ; Baird JK; Day NP; Price RN
    PLoS Negl Trop Dis; 2023 Sep; 17(9):e0011522. PubMed ID: 37672548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G6PD deficiency in Latin America: systematic review on prevalence and variants.
    Monteiro WM; Val FF; Siqueira AM; Franca GP; Sampaio VS; Melo GC; Almeida AC; Brito MA; Peixoto HM; Fuller D; Bassat Q; Romero GA; Maria Regina F O; Marcus Vinícius G L
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):553-68. PubMed ID: 25141282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea.
    Bahk YY; Ahn SK; Lee J; Im JH; Yeom JS; Park S; Kwon J; Kan H; Kim M; Jang W; Kim TS
    Korean J Parasitol; 2021 Oct; 59(5):447-455. PubMed ID: 34724763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
    Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
    PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
    Baird K
    Pathog Glob Health; 2015 May; 109(3):93-106. PubMed ID: 25943156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.